Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MEDLEYTSE:4480 +2.71%77 3-1 Month Momentum % is 31.35% as of Sep. 15, 2026. GuruFocus rates TSE:4480 with a GF Score™ of 77/100 and a GF Value™ of 円8,525.46 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 671 Healthcare Providers & Services companies, MEDLEY ranks better than 91.65% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-15), MEDLEY's 3-1 Month Momentum % is 31.35%.
The industry rank for MEDLEY's 3-1 Month Momentum % or its related term are showing as below:
TSE:4480's 3-1 Month Momentum % is ranked better than 91.65% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 1.43
vs TSE:4480: 31.35
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MEDLEY 3-1 Month Momentum % Related Terms
TSE:4480 vs VEEV, BTSG, TEM: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, MEDLEY's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDLEY 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MEDLEY's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDLEY (TSE:4480) has a 3-1 Month Momentum % of 31.35% as of Sep. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MEDLEY and its competitors. According to the industry distribution chart, MEDLEY ranks #56 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 8.3%.
Is MEDLEY's 3-1 Month Momentum % too high?
MEDLEY's current 3-1 Month Momentum % is 31.35%. The Healthcare Providers & Services industry median 3-1 Month Momentum % is 1.43. MEDLEY's value of 31.35% is 2092.3% above this industry median. Based on the distribution chart, MEDLEY ranks #56 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MEDLEY has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MEDLEY ranks #56 out of 671 companies for 3-1 Month Momentum %. This places MEDLEY in the top 8% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 1.43. MEDLEY's value of 31.35% is 2092.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 1.43, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDLEY's current 3-1 Month Momentum % of 31.35% is 2092.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MEDLEY and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDLEY's current 3-1 Month Momentum % is 31.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (TSE:4480) is currently considered Significantly Undervalued. The stock's GF Value™ is 円8,525.46, compared to a current price of 円2,422.00 — trading 71.6% below its estimated fair value. The current 3-1 Month Momentum % is 31.35% and 2092.3% above the Healthcare Providers & Services industry median of 1.43. MEDLEY's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For MEDLEY (TSE:4480), the current 3-1 Month Momentum % is 31.35% as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDLEY (TSE:4480) Overvalued in 2026?
Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued.
The current stock price of 円2,422.00 is trading 71.6% below its estimated GF Value™ of 円8,525.46.
GuruFocus considers MEDLEY to be Significantly Undervalued.
Key valuation signals for TSE:4480:
3-1 Month Momentum %: 31.35%
GF Value™: 円8,525.46 vs. price of 円2,422.00 (71.6% below fair value)
Industry Position: 2092.3% above the Healthcare Providers & Services median (#56 of 671)
No single metric tells the full story. See the TSE:4480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
77GF Score
Get the complete analysis for TSE:4480
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4480 has been successfully added to your 
